B
Bioventus Inc
NASDAQ:BVS
Bioventus Inc
NASDAQ:BVS
Price:
6.63 USD
4.41%
Market Closed
Updated:
May 17, 2024
Bioventus Inc
Gross Profit
|
Bioventus Inc
Gross Profit Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
Bioventus Inc
NASDAQ:BVS
|
Gross Profit
$331.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Gross Profit
$2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Gross Profit
$2.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Gross Profit
$2.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Gross Profit
$874.3m
|
CAGR 3-Years
82%
|
CAGR 5-Years
38%
|
CAGR 10-Years
26%
|
See Also
What is Bioventus Inc's Gross Profit?
Gross Profit
331.1m
USD
331.1m
USD
Based on the financial report for Dec 31, 2022, Bioventus Inc's Gross Profit amounts to 331.1m USD.
What is Bioventus Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
10%
10%
Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for Bioventus Inc have been 10% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
